Table I.
Probe | |||
---|---|---|---|
Pathway | P value | aTotal | bChanging |
Rank-based test | |||
Complement and coagulation cascades | 0.002 | 123 | 18 |
Hematopoietic cell lineage | 0.002 | 253 | 13 |
Olfactory transduction | 0.003 | 914 | 2 |
Pantothenate and CoA biosynthesis | 0.008 | 26 | 1 |
Systemic lupus erythematosus | 0.013 | 222 | 11 |
Cytokine-cytokine receptor interaction | 0.018 | 652 | 33 |
gamma-Hexachlorocyclohexane degradation | 0.021 | 27 | 3 |
Neuro active ligand-receptor interaction | 0.041 | 421 | 3 |
Toll-like receptor signaling pathway | 0.045 | 332 | 11 |
Design-based test | |||
Cytokine-cytokine receptor interaction | 0.001 | 652 | 33 |
Pantothenate and CoA biosynthesis | 0.001 | 26 | 1 |
Hematopoietic cell lineage | 0.006 | 253 | 13 |
Complement and coagulation cascades | 0.011 | 123 | 18 |
Systemic lupus erythematosus | 0.017 | 222 | 11 |
ABC transporters | 0.018 | 87 | 2 |
Natural killer cell mediated cytotoxicity | 0.018 | 334 | 13 |
T cell receptor signaling pathway | 0.019 | 352 | 11 |
gamma-Hexachlorocyclohexane degradation | 0.026 | 27 | 3 |
Fc epsilon RI signaling pathway | 0.029 | 243 | 13 |
Asthma | 0.032 | 87 | 3 |
Jak-STAT signaling pathway | 0.032 | 390 | 10 |
Linoleic acid metabolism | 0.041 | 53 | 6 |
Total indicates the total number of known probes in a given pathway.
Changing indicates the number of probes changing in a given pathway following the exposure.